Codes / ICD10CM / F15.129

F15.129 Other stimulant abuse with intoxication, unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other stimulant abuse with intoxication, unspecified (ICD-10 Code: F15.129)

Summary

This condition involves the misuse or excessive use of stimulant substances, excluding cocaine, leading to clinically significant impairment or distress with acute intoxication. Stimulants increase central nervous system activity, and their abuse can result in behavioral, psychological, or physiological issues, including acute intoxication symptoms without further specification of complications.

Causes

The condition is primarily driven by the intentional misuse of stimulant drugs. These may include prescription medications (e.g., amphetamines, methylphenidate) or illicit substances (e.g., methamphetamine). Prolonged or repeated use, often for non-medical reasons, contributes to the development of abuse patterns and intoxication episodes.

Risk Factors

  • History of substance use or addiction.
  • High-stress environments or peer pressure.
  • Pre-existing mental health disorders (e.g., anxiety, depression).
  • Access to stimulant medications or illicit drugs.
  • Genetic or familial predisposition to substance-related issues.

Symptoms

  • Compulsive use of stimulants despite negative consequences.
  • Cravings or strong urges to use stimulants.
  • Neglect of personal, occupational, or social responsibilities.
  • Continued use despite relationship or health problems.
  • Tolerance (needing more of the substance to achieve the desired effect).
  • Withdrawal symptoms when not using.

Diagnosis

Diagnosis involves a clinical evaluation of substance use history, behavioral patterns, and physiological symptoms. Healthcare providers assess for acute intoxication signs, such as elevated heart rate, agitation, or impaired judgment. Laboratory tests may be used to confirm stimulant presence, though clinical judgment remains key. The unspecified nature of this code indicates that specific complications (e.g., delirium, psychosis) are not documented.

Treatment Options

Treatment typically includes detoxification to manage withdrawal, followed by behavioral therapies (e.g., cognitive-behavioral therapy) to address underlying use patterns. Medications may be used to reduce cravings or stabilize mood. Supportive care, such as hydration and monitoring, addresses acute intoxication symptoms. Long-term recovery often involves ongoing counseling and support groups.

Prognosis and Follow-Up

Prognosis depends on the severity of use, presence of co-occurring disorders, and engagement in treatment. Early intervention improves outcomes, but relapse is common. Follow-up care focuses on monitoring for recurrence, addressing co-occurring conditions, and supporting sustained recovery through regular check-ins and therapy.

Complications

Potential complications include cardiovascular issues (e.g., arrhythmias), neurological problems (e.g., seizures), psychological effects (e.g., anxiety or paranoia), and social or occupational impairment. Chronic use may lead to organ damage or increased risk of overdose.

Lifestyle & Prevention

Prevention strategies include education on stimulant risks, safe storage of prescription medications, and avoiding non-medical use. Lifestyle modifications, such as stress management and healthy coping mechanisms, reduce the likelihood of misuse. Support from family or community resources can aid in maintaining abstinence.

When to Seek Professional Help

Seek help if stimulant use causes negative consequences (e.g., relationship issues, health problems) or if withdrawal symptoms occur. Immediate medical attention is needed for severe intoxication signs, such as chest pain, extreme agitation, or difficulty breathing.

Tips for Medical Coders

Use F15.129 when documenting other stimulant abuse with intoxication where no specific complications are noted. Ensure clinical documentation supports the presence of intoxication and the absence of specified complications (e.g., delirium, psychosis). Verify that stimulant use is non-cocaine and aligns with the "unspecified" designation.

Medical Policies and Guidelines

Related policies from health plans